Acemetacin-induced fixed drug eruption

Fixed drug eruption (FDE) is an adverse effect observed with various drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) and various antibiotics. Acemetacin, a prodrug of indomethacin, is an NSAID licensed for use in rheumatic disease and other musculoskeletal disorders. We present a case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cebeci, Filiz, Yaşar, Şirin, Aytekin, Sema, Güneş, Pembegül
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825444/
https://www.ncbi.nlm.nih.gov/pubmed/27114641
http://dx.doi.org/10.4103/0253-7613.178824
_version_ 1782426221938737152
author Cebeci, Filiz
Yaşar, Şirin
Aytekin, Sema
Güneş, Pembegül
author_facet Cebeci, Filiz
Yaşar, Şirin
Aytekin, Sema
Güneş, Pembegül
author_sort Cebeci, Filiz
collection PubMed
description Fixed drug eruption (FDE) is an adverse effect observed with various drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) and various antibiotics. Acemetacin, a prodrug of indomethacin, is an NSAID licensed for use in rheumatic disease and other musculoskeletal disorders. We present a case of acemetacin-induced FDE in a 49-year-old woman. To the best of our knowledge, this is the second case report detailing clinical and histopathological findings of a patient with FDE caused by acemetacin.
format Online
Article
Text
id pubmed-4825444
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-48254442016-04-25 Acemetacin-induced fixed drug eruption Cebeci, Filiz Yaşar, Şirin Aytekin, Sema Güneş, Pembegül Indian J Pharmacol Drug Watch Fixed drug eruption (FDE) is an adverse effect observed with various drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) and various antibiotics. Acemetacin, a prodrug of indomethacin, is an NSAID licensed for use in rheumatic disease and other musculoskeletal disorders. We present a case of acemetacin-induced FDE in a 49-year-old woman. To the best of our knowledge, this is the second case report detailing clinical and histopathological findings of a patient with FDE caused by acemetacin. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4825444/ /pubmed/27114641 http://dx.doi.org/10.4103/0253-7613.178824 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Drug Watch
Cebeci, Filiz
Yaşar, Şirin
Aytekin, Sema
Güneş, Pembegül
Acemetacin-induced fixed drug eruption
title Acemetacin-induced fixed drug eruption
title_full Acemetacin-induced fixed drug eruption
title_fullStr Acemetacin-induced fixed drug eruption
title_full_unstemmed Acemetacin-induced fixed drug eruption
title_short Acemetacin-induced fixed drug eruption
title_sort acemetacin-induced fixed drug eruption
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825444/
https://www.ncbi.nlm.nih.gov/pubmed/27114641
http://dx.doi.org/10.4103/0253-7613.178824
work_keys_str_mv AT cebecifiliz acemetacininducedfixeddrugeruption
AT yasarsirin acemetacininducedfixeddrugeruption
AT aytekinsema acemetacininducedfixeddrugeruption
AT gunespembegul acemetacininducedfixeddrugeruption

Ejemplares similares